Page last updated: 2024-08-23

silybin and carboplatin

silybin has been researched along with carboplatin in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Agarwal, P; Agarwal, R; Dhanalakshmi, S; Glode, LM1
Agarwal, C; Agarwal, R; Chan, DC; Tyagi, AK1

Other Studies

2 other study(ies) available for silybin and carboplatin

ArticleYear
Silibinin sensitizes human prostate carcinoma DU145 cells to cisplatin- and carboplatin-induced growth inhibition and apoptotic death.
    International journal of cancer, 2003, Sep-20, Volume: 106, Issue:5

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Blotting, Western; Carboplatin; Caspases; Cell Cycle; Cisplatin; Cytochrome c Group; Drug Resistance, Neoplasm; Flow Cytometry; Humans; Immunoblotting; Male; Poly(ADP-ribose) Polymerases; Prostatic Neoplasms; Silybin; Silybum marianum; Silymarin; Tumor Cells, Cultured

2003
Synergistic anti-cancer effects of silibinin with conventional cytotoxic agents doxorubicin, cisplatin and carboplatin against human breast carcinoma MCF-7 and MDA-MB468 cells.
    Oncology reports, 2004, Volume: 11, Issue:2

    Topics: Anticarcinogenic Agents; Breast Neoplasms; Carboplatin; Cell Division; Cell Line, Tumor; Cell Survival; Cisplatin; Doxorubicin; Drug Synergism; Female; Humans; Kinetics; Silybin; Silybum marianum; Silymarin

2004